Search or choose
Find the right test or package.
CLL Prognostication/Risk Stratification Gene Panel
The CLL Prognostication/Risk Stratification Gene Panel is an advanced genetic test that helps predict how Chronic Lymphocytic Leukemia (CLL) is likely to progress. It detects specific gene mutations linked to disease behavior, treatment response, and overall p...
DiagnosticsLab test
Know more about this test
The CLL Prognostication/Risk Stratification Gene Panel is an advanced genetic test that helps predict how Chronic Lymphocytic Leukemia (CLL) is likely to progress. It detects specific gene mutations linked to disease behavior, treatment response, and...
Understanding CLL Prognostication/Risk Stratification Gene Panel
The CLL Prognostication/Risk Stratification Gene Panel is a Next-Generation Sequencing (NGS)–based molecular test performed on EDTA whole blood samples. It analyzes key genes and mutations linked with the development and behavior of Chronic Lymphocytic Leukemia (CLL), a cancer of the blood and bone marrow that affects white blood cells.
CLL is a heterogeneous disease, meaning it behaves differently in every patient. Some cases progress slowly and require only monitoring, while others are more aggressive and...
What does CLL Prognostication/Risk Stratification Gene Panel measure?
The CLL Prognostication/Risk Stratification Gene Panel is an advanced genetic test that helps predict how Chronic Lymphocytic Leukemia (CLL) is likely to progress. It detects specific gene mutations linked to disease behavior, treatment response, and overall prognosis. This information helps doctors personalize treatment and make better-informed decisions for managing CLL.
Related parameters
How does home sample collection work?
Select slot
Pick a convenient time.
Phlebotomist visit
A trained expert arrives home.
Safe testing
Samples move through the lab process.
Digital reports
Reports are delivered online.